A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Nishitha Reddy
Eikon Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Care Northern Beaches
Frenchs Forest, New South Wales, Australia
Recruiting - Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia
Recruiting - Peninsula and Southeast Oncology (paso) Medical
Frankston, Victoria, Australia
Recruiting - Sunshine Hospital - Western Health
Saint Albans, Victoria, Australia
Recruiting
- Centre Hospitalier Universitaire Brugmann
Brussels, Belgium
Recruiting
- University Hospital Carl Gustav Carus Dresden
Dresden, Saxony, Germany
Recruiting
- Henry Dunant Hospital Center
Athens, Greece
Recruiting
- Gcpmed Sp. Z O.O., Centrum Medyczne Imed24
Krakow, Lesser Poland Voivodeship, Poland
Recruiting
- Task Eden
George, Western Cape, South Africa
Recruiting
- Yeungnam University College of Medicine
Daegu, Daegu, South Korea
Recruiting - Gachon University - Gil Medical Center
Incheon, Incheon Gwang'Yeogsi, South Korea
Recruiting
- Hospital Universitario de Jerez de la Frontera
Jerez de la Frontera, Cadiz, Spain
Recruiting - Consorci Hospitalari Provincial de Castello
Castellon, Castellón, Spain
Recruiting - Instituto Oncologico Dr. Rosell (ior)
Barcelona, Spain
Recruiting - Institut Catala D'Oncologia de Girona
Girona, Spain
Recruiting - Hospital Quirónsalud Málaga
Málaga, Spain
Recruiting
- Southern Cancer Center, P.C.
Daphne, Alabama, United States
Recruiting - Los Angeles Cancer Network
Glendale, California, United States
Recruiting - Providence St. Joseph Hospital
Orange, California, United States
Recruiting - Rocky Mountain Cancer Centers, Llp
Pueblo, Colorado, United States
Recruiting - Florida Clinical Trials Group
Plantation, Florida, United States
Recruiting - Florida Clinical Trials Group - Tamarac
Tamarac, Florida, United States
Recruiting - Osf Saint Francis Medical Center
Peoria, Illinois, United States
Recruiting - University of New Mexico - Comprehensive Cancer Center
Albuquerque, New Mexico, United States
Recruiting - Nyu Langone Hospital Long Island
Mineola, New York, United States
Recruiting - Nyu Langone Hospital Manhattan
New York, New York, United States
Recruiting - Jacobi Medical Center - Albert Einstein College of Medicine
The Bronx, New York, United States
Recruiting - White Plains Hospital
White Plains, New York, United States
Recruiting - Tennessee Oncology
Nashville, Tennessee, United States
Recruiting - Blue Ridge Cancer Center
Blacksburg, Virginia, United States
Recruiting - Virginia Cancer Specialists, Pc
Fairfax, Virginia, United States
Recruiting - Shenandoah Oncology P.C.
Winchester, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jun 2026
- Primary completion
- 31 Dec 2035
- Completion
- 31 Dec 2040
- Last update posted
- 20 Oct 2026
- Registered enrollment
- 750
- Registry id
- NCT07365319
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.